NewEdge Advisors’s RxSight RXST Stock Holding History

NewEdge Advisors’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,600	Closed	-$14.4K	–	4356
2025 Q3	$14.4K	Hold	1,600	–	–	﹤0.01%	3234
2025 Q2	$20.8K	Hold	1,600	–	–	﹤0.01%	2949
2025 Q1	$40.4K	Sell	1,600 -3	-0.2%	-$89	﹤0.01%	2622
2024 Q4	$55.1K	Sell	1,603 -300	-16%	-$13.5K	﹤0.01%	2492
2024 Q3	$94.1K	Hold	1,903	–	–	﹤0.01%	2213
2024 Q2	$115K	Sell	1,903 -77	-4%	-$4.4K	﹤0.01%	2080
2024 Q1	$102K	Hold	1,980	–	–	﹤0.01%	2060
2023 Q4	$79.8K	Hold	1,980	–	–	﹤0.01%	2036
2023 Q3	$55.2K	Hold	1,980	–	–	﹤0.01%	2065
2023 Q2	$57K	Sell	1,980 -140	-7%	-$3.11K	﹤0.01%	2045
2023 Q1	$35.4K	Buy	2,120 +420	+25%	+$5.93K	﹤0.01%	2141
2022 Q4	$22	Buy	+1,700	New	+$20.7K	﹤0.01%	3586

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

NewEdge Advisors's RXST Position: Q4 2025 in Review

NewEdge Advisors sold out of RxSight (RXST) in Q4 2025, closing a stake of 1,600 shares — an estimated $14.4K sold.

NewEdge Advisors first reported a position in RXST in Q4 2022 and held it in 12 quarters. The position peaked at $115K in Q2 2024. 163 funds tracked by Wall St. Rank hold RXST as of Q4 2025.

NewEdge Advisors reported no remaining RxSight position as of Q4 2025 after selling out during the quarter.
NewEdge Advisors sold 1,600 RxSight shares in Q4 2025, an estimated $14.4K.
NewEdge Advisors first reported a position in RxSight in Q4 2022 and held it in 12 quarters.
NewEdge Advisors's RxSight position peaked at $115K in Q2 2024.
163 funds tracked by Wall St. Rank held RxSight as of Q4 2025.

Based on NewEdge Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.